Page last updated: 2024-12-08
trimix
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
trimix: mixture of 3 gases used for breathing by divers [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 174735 |
MeSH ID | M0131685 |
Synonyms (7)
Synonym |
---|
trimix |
helium, mixt. with nitrogen and oxygen |
hwq5kfy3mu , |
unii-hwq5kfy3mu |
89210-11-7 |
DTXSID80237574 |
helium;molecular nitrogen;molecular oxygen |
Research Excerpts
Overview
Trimix is a widely prescribed penile injection for patients with erectile dysfunction. It is only available as a compounded medication.
Excerpt | Reference | Relevance |
---|---|---|
"Trimix is a widely prescribed penile injection for patients with erectile dysfunction and is only available as a compounded medication. " | ( Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design. Anderson, S; Banov, D; Bassani, AS; Byrne, R; Caputo, R; Davis, C; Debideen, KE; Herr, D; Ip, K; Liu, Y; Patel, G; Rhoads, MM, ) | 1.9 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (30)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (13.33) | 18.7374 |
1990's | 2 (6.67) | 18.2507 |
2000's | 11 (36.67) | 29.6817 |
2010's | 11 (36.67) | 24.3611 |
2020's | 2 (6.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 64.97
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (64.97) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 2 (5.41%) | 5.53% |
Reviews | 2 (5.41%) | 6.00% |
Case Studies | 3 (8.11%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 30 (81.08%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |